Skip Navigation

Vaccines

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Vaccine Research

Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.

NIAID Research

Highlights

Chinnaswamy Jagannath, Ph.D. Woman giving injection to child
 

Overcoming Challenges in Staphylococcus aureus Vaccine Development - Meeting Summary, June 7, 2013 (PDF)

Two-Dose Rotavirus Vaccine Regimen Initiated During Newborn Period Prevents Rotavirus Diarrhea

Rabies Vaccine Protects Nonhuman Primates against Deadly Ebola Virus

Jordan Report: Accelerated Development of Vaccines 2012

Videocast: HHS Science Seminar for Media—Advances in Influenza Vaccine Technologies

NIAID Network of Vaccine and Treatment Evaluation Units (VTEUs)

Recent Successes in Developing an HIV Vaccine

NIAID Lab Developing Intranasal RSV Vaccines

NIAID Scientists Use Reverse Genetics to Develop Potential Dengue Vaccine

Flu Shots No More? NIAID Grantees Use New Skin Patches to Deliver Flu Vaccine in Mice

Program Announcement

Research to Advance Vaccine Safety (R01 and R21)

What's New

Experimental Chikungunya Vaccine Induces Robust Antibody Response—Aug. 14, 2014

Media Availability: Vaccine Made from Complex of Two Malaria Proteins Protects Mice From Lethal Infection—June 23, 2014

Media Availability: Tdap Vaccination During Pregnancy Likely to Protect Newborns from Pertussis—May 3, 2014

Media Availability: International Scientists Convene to Chart Path, Measure Progress Toward Global Vaccine Research and Development—March 3, 2014

All Vaccine News Releases

News From NIAID-Supported Institutions

Last Updated August 14, 2014